Viropro Inc. announced that on October 17, 2012, Mr. Emilio Binavince and Dr. Scott Brown resigned as members of its Board of Directors, and on October 19, 2012 Dr. Rajiv Datar resigned as a member of its Board of Directors, leaving Ms. Cynthia Tsai as its only remaining director. As authorized by Nevada law and its Articles of Incorporation, Ms. Tsai, as the sole director, appointed Dr. Ken Sorensen, Dr. Ann Rose and Ms. Michelle Peake as the new directors to fill the vacancies created by the resignations, until the next shareholder meeting at which directors shall be elected and qualified. Dr. Ann H. Rose is President/CEO of ViCro.

Prior to founding ViCro, Dr. Rose was invited to join the staff of the U.S. Congress in 1981 as a health technology analyst, where she influenced congressional health policy decision-making. Ms. Michelle Peake has 17 years of international experience in biotechnology, specializing in cGMP manufacture, protein purification and fill/finish, including process development. Ms. Peake also has experience in laboratory design and build, including the design and construction of a cGMP compliant biologics manufacturing facility in Penang, Malaysia and obtaining cGMP accreditation for a facility in the United Kingdom.

Currently, Ms. Peake is the CEO of Alpha Biologics Sdn Bhd - a position she gained after being promoted from various positions with the company that she has held since 2003. Kenneth A. Sorensen, Ph.D., Patent Agent focuses on scientific due diligence, intellectual property analysis, market analysis, technology/IP Valuations, and research to identify appropriate corporate partners other business development and management support activities for portfolio companies.